NASDAQ:MOTS Motus GI (MOTS) Stock Price, News & Analysis → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free MOTS Stock Alerts $0.18 +0.02 (+12.50%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$0.17▼$0.1950-Day Range$0.07▼$0.4752-Week Range$0.05▼$14.25Volume115,454 shsAverage Volume126,772 shsMarket Capitalization$905,400.00P/E RatioN/ADividend YieldN/APrice Target$28.88 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Motus GI alerts: Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. About Motus GI Stock (NASDAQ:MOTS)Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Read More MOTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MOTS Stock News HeadlinesMay 14, 2024 | msn.comMOTS Stock Earnings: Motus GI Hldgs Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | finance.yahoo.comMotus GI Reports First Quarter 2024 Financial Results and Provides Corporate UpdateApril 16, 2024 | morningstar.comMotus GI Holdings IncApril 12, 2024 | msn.comWhy Is Motus GI (MOTS) Stock Down 37% Today?April 12, 2024 | investorplace.comWhy Is Motus GI (MOTS) Stock Down 37% Today?March 23, 2024 | msn.comMotus GI Holdings files to sell 4.4M common shares for holdersMarch 19, 2024 | finanznachrichten.deMotus GI Holdings, Inc.: Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 18, 2024 | investorplace.comMOTS Stock Earnings: Motus GI Hldgs Misses EPS, Misses Revenue for Q4 2023March 18, 2024 | fr.investing.comLe BPA de Motus GI Holdings a dépassé les attentes de 1,30$, le CA en dessous des prévisionsMarch 18, 2024 | globenewswire.comMotus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finance.yahoo.comMotus GI Holdings, Inc. (MOTS)February 29, 2024 | businesswire.comEndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive OfficerFebruary 23, 2024 | investing.comMotus GI secures new patent for endoscopic proceduresFebruary 23, 2024 | wsj.comMotus GI Holdings Inc.February 22, 2024 | finance.yahoo.comMotus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross ProceedsFebruary 22, 2024 | globenewswire.comMotus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross ProceedsFebruary 21, 2024 | msn.comWhy Is Colonoscopy-Focused Motus GI Stock Trading Higher Today?February 21, 2024 | markets.businessinsider.comCrude Oil Moves Higher; Exelon Earnings Top EstimatesFebruary 21, 2024 | fr.investing.comMotus GI obtient un nouveau brevet pour les procédures endoscopiquesFebruary 21, 2024 | finance.yahoo.comMotus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI TractFebruary 21, 2024 | globenewswire.comMotus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI TractFebruary 16, 2024 | finance.yahoo.comMotus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of StockholdersFebruary 16, 2024 | globenewswire.comMotus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of StockholdersFebruary 14, 2024 | investing.comMotus GI Holdings Inc (MOTS)February 8, 2024 | morningstar.comMotus GI Holdings Inc MOTSSee More Headlines Receive MOTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today6/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MOTS CUSIPN/A CIK1686850 Webwww.motusgi.com Phone(954) 541-8000Fax954-541-8265Employees15Year FoundedN/APrice Target and Rating Average Stock Price Target$28.88 High Stock Price Target$37.50 Low Stock Price Target$20.25 Potential Upside/Downside+15,941.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($15.6370) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,870,000.00 Net Margins-3,239.75% Pretax Margin-3,239.75% Return on Equity-1,731.08% Return on Assets-115.99% Debt Debt-to-Equity Ratio0.22 Current Ratio1.74 Quick Ratio1.67 Sales & Book Value Annual Sales$320,000.00 Price / Sales2.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.61 per share Price / Book0.30Miscellaneous Outstanding Shares5,030,000Free Float4,952,000Market Cap$905,400.00 OptionableNot Optionable Beta1.50 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Mark Pomeranz (Age 62)Non-Independent Director & CEO Comp: $877.1kMs. Ravit Ram (Age 49)CFO & VP of Global Operations Comp: $371.58kMr. Elad Amor (Age 40)Chief Accounting Officer Comp: $349.87kKey CompetitorsAssureNASDAQ:IONMReShape LifesciencesNASDAQ:RSLSTenon MedicalNASDAQ:TNONDynatronicsNASDAQ:DYNTNemaura MedicalNASDAQ:NMRDView All Competitors MOTS Stock Analysis - Frequently Asked Questions Should I buy or sell Motus GI stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MOTS shares. View MOTS analyst ratings or view top-rated stocks. What is Motus GI's stock price target for 2024? 1 Wall Street analysts have issued 12 month price targets for Motus GI's shares. Their MOTS share price targets range from $20.25 to $37.50. On average, they expect the company's share price to reach $28.88 in the next twelve months. This suggests a possible upside of 15,941.7% from the stock's current price. View analysts price targets for MOTS or view top-rated stocks among Wall Street analysts. How have MOTS shares performed in 2024? Motus GI's stock was trading at $1.2750 at the start of the year. Since then, MOTS stock has decreased by 85.9% and is now trading at $0.18. View the best growth stocks for 2024 here. How were Motus GI's earnings last quarter? Motus GI Holdings, Inc. (NASDAQ:MOTS) posted its earnings results on Tuesday, May, 14th. The company reported ($0.88) EPS for the quarter. The firm earned $0.06 million during the quarter. Motus GI had a negative trailing twelve-month return on equity of 1,731.08% and a negative net margin of 3,239.75%. When did Motus GI's stock split? Shares of Motus GI reverse split before market open on Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of Motus GI own? Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Matinas BioPharma (MTNB), Allena Pharmaceuticals (ALNA), VYNE Therapeutics (VYNE), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE), Pfizer (PFE), Gilead Sciences (GILD) and Marinus Pharmaceuticals (MRNS). When did Motus GI IPO? Motus GI (MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager. How do I buy shares of Motus GI? Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MOTS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.